Bright Green Corporation

2.26+0.0400+1.80%Vol 193.31K1Y Perf -
Jul 1st, 2022 16:00 DELAYED
BID2.21 ASK2.36
Open2.28 Previous Close2.22
Pre-Market- After-Market2.25
 - -  -0.01 -0.44%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.18 
Earnings Rating
Market Cap361.19M 
Earnings Date
-
Alpha Standard Deviation
Beta 

Today's Price Range

2.202.35

52W Range

2.1658.00

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Neutral
Performance
1 Week
-20.42%
1 Month
-37.22%
3 Months
-
6 Months
-
1 Year
-
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BGXX2.260.04001.80
AAPL138.932.21001.62
GOOG2 181.62-5.8300-0.27
MSFT259.582.75001.07
XOM87.551.91002.23
WFC39.920.75001.91
JNJ179.522.01001.13
FB196.640.99000.51
GE63.54-0.1300-0.20
JPM114.051.44001.28
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume193.31K
Shares Outstanding159.82K
Shares Float159.82M
Trades Count2.36K
Dollar Volume436.78K
Avg. Volume1.40M
Avg. Weekly Volume358.63K
Avg. Monthly Volume1.63M
Avg. Quarterly Volume2.20M

Bright Green Corporation (NASDAQ: BGXX) stock closed at 2.26 per share at the end of the most recent trading day (a 1.8% change compared to the prior day closing price) with a volume of 193.31K shares and market capitalization of 361.19M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 0 people. Bright Green Corporation CEO is .

The one-year performance of Bright Green Corporation stock is %, while year-to-date (YTD) performance is %. BGXX stock has a five-year performance of %. Its 52-week range is between 2.16 and 58, which gives BGXX stock a 52-week price range ratio of 0.18%

Bright Green Corporation currently has a PE ratio of -163.50, a price-to-book (PB) ratio of 60.16, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -31.02%, a ROC of -35.89% and a ROE of -35.89%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Bright Green Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Bright Green Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Bright Green Corporation is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Bright Green Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bright Green Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bright Green Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 83.93, ATR14 : 0.21, CCI20 : -142.12, Chaikin Money Flow : -0.17, MACD : -2.81, Money Flow Index : 70.18, ROC : -15.04, RSI : 34.64, STOCH (14,3) : 8.97, STOCH RSI : 0.14, UO : 34.45, Williams %R : -91.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bright Green Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Bright Green Corporation

Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).

CEO:

Telephone: +1 201 370-1140

Address: 401 East Las Olas Boulevard, Ft. Lauderdale 33301, FL, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits